Citations 1
Phase 2 study of veliparib plus FOLFIRI ± bevacizumab versus placebo plus FOLFIRI ± bevacizumab in metastatic colorectal cancer.
Горбунова, В. А. , Beck, Thaddeus, Hofheinz, Ralf‐Dieter , García‐Alfonso, Pilar , Nechaeva, Marina , Gracián, Antonio Cubillo, Mangel, László, Deming, Dustin A. , Ramanathan, Ramesh K., Torres, Alison Hewitt, Sullivan, Danielle, Komarnitsky, Philip, Élez, Elena , Berlin, Jordan D.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 3543-3543
